The gold standard of anti-CCP (citrullinated peptide) testing
The gold standard of anti-CCP testing
Our CCP Solutions
Didn't find what you were looking for?
We offer products customized to your needs. Our custom iLite® reporter-gene assays can be adapted to almost any target. We also offer custom ELISA plates and other products. In addition, you can take advantage of our service offerings and let us do the work for you.
FAQ
What are anti-CCP antibodies?
Anti-cyclic citrullinated peptide (anti-CCP) antibodies are autoantibodies directed against citrullinated proteins. They are highly associated with rheumatoid arthritis and are commonly used as diagnostic and prognostic biomarkers.
Why is anti-CCP testing used in rheumatoid arthritis?
Anti-CCP testing is used to support the diagnosis of rheumatoid arthritis (RA) and to help identify patients at risk of developing persistent or progressive disease. The presence of anti-CCP antibodies is strongly associated with rheumatoid arthritis.
What is the clinical significance of anti-CCP antibodies?
The presence of anti-CCP antibodies is associated with rheumatoid arthritis and may indicate a higher likelihood of disease progression and joint damage. Anti-CCP testing therefore provides both diagnostic and prognostic value.
What is the difference between anti-CCP and rheumatoid factor (RF)?
Anti-CCP antibodies and rheumatoid factor are both used in the evaluation of rheumatoid arthritis. However, anti-CCP antibodies generally offer higher specificity for rheumatoid arthritis, while rheumatoid factor may be present in other autoimmune or inflammatory conditions.
Why is anti-CCP2 considered the gold standard?
Anti-CCP2 assays are widely used because they provide high clinical sensitivity and specificity for rheumatoid arthritis. They have become an established standard for anti-CCP antibody testing in both clinical practice and research.
Can anti-CCP antibodies be detected before rheumatoid arthritis symptoms develop?
Yes. Anti-CCP antibodies may be present months or even years before the onset of clinical symptoms. Their detection can support early identification of individuals at increased risk of developing rheumatoid arthritis.
Can anti-CCP antibodies be detected before rheumatoid arthritis symptoms develop?
Yes. Anti-CCP antibodies may be present months or even years before the onset of clinical symptoms. Their detection can support early identification of individuals at increased risk of developing rheumatoid arthritis.
How can anti-CCP testing support disease management and follow-up?
Anti-CCP testing can contribute to a more complete understanding of a patient's disease profile and may help clinicians assess prognosis and support long-term disease management decisions.
Why choose Svar's anti-CCP solutions?
Svar Life Science combines extensive expertise in autoimmune diagnostics with established anti-CCP technologies. Our solutions are designed to support reliable antibody detection and consistent laboratory performance in rheumatoid arthritis testing. We offer both IVD and RUO solutions.
